New targets and drugs in cancer chemotherapy

被引:6
作者
Szekeres, T [1 ]
Novotny, L [1 ]
机构
[1] Univ Vienna, Sch Med, Gen Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria
关键词
cancer chemotherapy; apoptosis; drug targets; antitumor strategies;
D O I
10.1159/000063243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer is still the number two cause of death in highly developed countries. Due to increased life expectancy, the number of cancer cases has also increased, and it is not likely that the incidence of this often fatal illness will decrease in the near future. Breast cancer, for instance, strikes 1 of 8 women in the industrialized world. Incidence of lung cancer increases due to smoking, while that of colon cancer increases with age. These are only a few examples highlighting the growing importance of strategies effective for cancer treatment. Despite surgical treatment and irradiation, chemotherapy remains one of the important means to treat cancer. Although many institutions and companies have tried to establish new treatment strategies such as immunotherapy or vaccination, the conventional chemotherapy still remains an important treatment option. In this review, we present an overview of new and innovative treatment strategies for cancer chemotherapy. A number of new targets as well as anticancer compounds are introduced and though we are well aware of the fact that the list is incomplete, we hope to be able to provide insight into this rapidly developing field. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 50 条
[41]   New drugs for the treatment of cancer, 1990-2001 [J].
Geffen, DB ;
Man, S .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (12) :1124-1131
[42]   Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? [J].
de Graaf, AO ;
de Witte, T ;
Jansen, JH .
LEUKEMIA, 2004, 18 (11) :1751-1759
[43]   Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? [J].
A O de Graaf ;
T de Witte ;
J H Jansen .
Leukemia, 2004, 18 :1751-1759
[44]   JNK signalling in cancer: in need of new, smarter therapeutic targets [J].
Bubici, Concetta ;
Papa, Salvatore .
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (01) :24-37
[45]   Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer [J].
Pang, Bing ;
Xu, Xiaoguang ;
Lu, Yao ;
Jin, Han ;
Yang, Rongrong ;
Jiang, Chunmei ;
Shao, Dongyan ;
Liu, Yanlin ;
Shi, Junling .
FOOD & FUNCTION, 2019, 10 (09) :5339-5349
[46]   DESIGNING PROLIFERATING CELL POPULATION MODELS WITH FUNCTIONAL TARGETS FOR CONTROL BY ANTI-CANCER DRUGS [J].
Billy, Frederique ;
Clairambault, Jean .
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B, 2013, 18 (04) :865-889
[47]   Multifunctional Enzymes as Targets for the Treatment of Tuberculosis: Paving the Way for New Anti-TB Drugs [J].
Teixeira, Carla Silvia Silva ;
Cerqueira, M. F. S. A. Nuno ;
Sousa, Sergio Filipe .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (28) :5847-5882
[48]   Atypical (RIO) protein kinases from Haemonchus contortus - Promise as new targets for nematocidal drugs [J].
Campbell, Bronwyn E. ;
Boag, Peter R. ;
Hofmann, Andreas ;
Cantacessi, Cinzia ;
Wang, Conan K. ;
Taylor, Paul ;
Hu, Min ;
Sindhu, Zia-ud-Din ;
Loukas, Alex ;
Sternberg, Paul W. ;
Gasser, Robin B. .
BIOTECHNOLOGY ADVANCES, 2011, 29 (03) :338-350
[49]   Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets [J].
Chi, Kim N. ;
Bjartell, Anders ;
Dearnaley, David ;
Saad, Fred ;
Schroeder, Fritz H. ;
Sternberg, Cora ;
Tombal, Bertrand ;
Visakorpi, Tapio .
EUROPEAN UROLOGY, 2009, 56 (04) :594-605
[50]   Antiangiogenic drugs:: Current knowledge and new approaches to cancer therapy [J].
Mauriz, Jose L. ;
Gonzalez-Gallego, Javier .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (10) :4129-4154